Access to Breast Cancer Diagnosis Act of 2025

United States119th CongressHR-3037House of Representatives
Updated: Apr 28, 2025

Summary

This bill aims to eliminate financial barriers to critical breast cancer detection by prohibiting group health plans and health insurance issuers from imposing cost-sharing requirements for diagnostic and supplemental breast examinations. It amends the Public Health Service Act to ensure that medically necessary services, including diagnostic mammography, MRI, and ultrasound, are covered without deductibles, copayments, or coinsurance. The legislation defines diagnostic breast examinations as those evaluating abnormalities and supplemental breast examinations as screenings for individuals with increased risk factors. While prohibiting cost-sharing, the bill allows plans to require prior authorization and applies to "grandfathered" health plans, without superseding stronger state laws. Additionally, it amends the Internal Revenue Code to permit high-deductible health plans (HDHPs) to cover these examinations without a deductible, preserving Health Savings Account (HSA) eligibility. These provisions will take effect for plan years beginning on or after January 1, 2026, enhancing access to essential breast cancer care.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

S-1500: Access to Breast Cancer Diagnosis Act of 2025

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  1. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  2. Introduced in House

All available records shown.